Metacrine, Inc. expected to post a loss of 61 cents a share - Earnings Preview

Metacrine

08/11/2021 16:12

* Metacrine, Inc.  MTCR.OQ   MTCR.O  is expected to show no
change in quarterly revenue when it reports  results on November
10 (estimated). 
​* Refinitiv's mean analyst estimate for Metacrine, Inc. is for
a loss of 61 cents per share. For the same quarter last year,
the company reported a loss of $1.41 per share.
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is 1 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Metacrine, Inc.
is $2.5​, about 47.6% above​ its last closing price
of $1.31. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Jun. 30 2021  -0.61       -0.60      -0.59     Beat    2.1
 Mar. 31 2021  -0.49       -0.51      -0.57     Missed  -12.5
 Dec. 31 2020  -0.36       -0.38      -1.15     Missed  -202.6
                                                        ​
 Sep. 30 2020  -0.41       -0.41      -1.41     Missed  -243.9
 ​​                                                     
                                                        ​
 This summary was machine generated November 8 at 16:12 GMT.  All
figures in US dollars unless otherwise stated